PCLOF (PharmaCielo) Other Stockholders Equity: $0.83 Mil (As of Dec. 2025)


What is PharmaCielo Other Stockholders Equity?

PharmaCielo PCLOF +27.76% Other Stockholders Equity is $0.83 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

PharmaCielo's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $0.83 Mil.

PharmaCielo's quarterly Other Stockholders Equity declined from Jun. 2025 ($0.83 Mil) to Sep. 2025 ($0.82 Mil) but then increased from Sep. 2025 ($0.82 Mil) to Dec. 2025 ($0.83 Mil).

PharmaCielo's annual Other Stockholders Equity declined from Dec. 2021 ($1.53 Mil) to Dec. 2022 ($0.41 Mil) but then increased from Dec. 2022 ($0.41 Mil) to Dec. 2023 ($0.59 Mil).

PharmaCielo Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for PharmaCielo's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCielo Other Stockholders Equity Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial 0.00 0.44 1.53 0.41 0.59

PharmaCielo Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.55 1.84 0.83 0.82 0.83

PharmaCielo Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.83 Mil mean?
PharmaCielo (PCLOF) has a Other Stockholders Equity of $0.83 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on PharmaCielo and its competitors.
Is PharmaCielo's Other Stockholders Equity too high?
PharmaCielo's current Other Stockholders Equity is $0.83 Mil.
How does PharmaCielo's Other Stockholders Equity compare to ZTS and UTHR?
PharmaCielo's Other Stockholders Equity of $0.83 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on PharmaCielo and its competitors. PharmaCielo's current Other Stockholders Equity is $0.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCielo stock overvalued right now?
Based on GuruFocus' analysis, PharmaCielo (PCLOF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.11, compared to a current price of $0.06 — trading 44.3% below its estimated fair value. The current Other Stockholders Equity is $0.83 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For PharmaCielo (PCLOF), the current Other Stockholders Equity is $0.83 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCielo Business Description

Other Exchanges PCLO:Canada
Address 82 Richmond Street East, Suite 805, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico and generates the majority of its revenue in the form of the Sale of Cannabis derivative products in America followed by Australia, Africa and Europe.